RT Journal Article
SR Electronic
T1 Molecular assessment of intratumoral immune cell subsets and potential mechanisms of resistance to odronextamab, a CD20×CD3 bispecific antibody, in patients with relapsed/refractory B-cell non-Hodgkin lymphoma
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e008338
DO 10.1136/jitc-2023-008338
VO 12
IS 3
A1 Brouwer-Visser, Jurriaan
A1 Fiaschi, Nathalie
A1 Deering, Raquel P
A1 Cygan, Kamil J
A1 Scott, Darius
A1 Jeong, Se
A1 Boucher, Lauren
A1 Gupta, Namita T
A1 Gupta, Suraj
A1 Adler, Christina
A1 Topp, Max S
A1 Bannerji, Rajat
A1 Duell, Johannes
A1 Advani, Ranjana H
A1 Flink, Dina M
A1 Chaudhry, Aafia
A1 Thurston, Gavin
A1 Ambati, Srikanth R
A1 Jankovic, Vladimir
YR 2024
UL http://jitc.bmj.com/content/12/3/e008338.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.